La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Easywell Biomedicals Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

James Aiping Lee

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	no data
Proprietà del CEO	0.1%
Durata media del management	Nessun dato
Durata media del Consiglio di amministrazione	Nessun dato

Aggiornamenti recenti sulla gestione

Recent updates

What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Feb 12

AMMINISTRATORE DELEGATO

James Aiping Lee

no data

Mandato

Mr. James Aiping Lee, Ph D, is President of Easywell Biomedicals, Inc and serves as its Manager. He has extensive experience in both medical device and pharmaceutical industries.As the founder of Magnific...

Easywell Biomedicals Gestione

Gestione criteri di controllo 0/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Easywell Biomedicals, Inc., Annual General Meeting, Jun 27, 2024

Recent updates

Second quarter 2024 earnings released: NT$0.18 loss per share (vs NT$0.22 loss in 2Q 2023)

Easywell Biomedicals, Inc. to Report Q2, 2024 Results on Aug 07, 2024

First quarter 2024 earnings released: NT$0.41 loss per share (vs NT$0.43 loss in 1Q 2023)

Easywell Biomedicals, Inc. announced a financing transaction

Full year 2023 earnings released: NT$1.27 loss per share (vs NT$1.41 loss in FY 2022)

Easywell Biomedicals, Inc., Annual General Meeting, Jun 27, 2024

New minor risk - Shareholder dilution

New minor risk - Share price stability

Second quarter 2023 earnings released: NT$0.22 loss per share (vs NT$0.33 loss in 2Q 2022)

Third quarter 2022 earnings released: NT$0.23 loss per share (vs NT$0.44 loss in 3Q 2021)

Third quarter 2022 earnings released: NT$0.23 loss per share (vs NT$0.44 loss in 3Q 2021)

Second quarter 2022 earnings released: NT$0.23 loss per share (vs NT$0.43 loss in 2Q 2021)

First quarter 2022 earnings released: NT$0.32 loss per share (vs NT$0.036 profit in 1Q 2021)

Full year 2021 earnings released: NT$0.99 loss per share (vs NT$1.30 loss in FY 2020)

Third quarter 2021 earnings released: NT$0.31 loss per share (vs NT$0.38 loss in 3Q 2020)

Second quarter 2021 earnings released: NT$0.43 loss per share (vs NT$0.42 loss in 2Q 2020)

First quarter 2021 earnings released: EPS NT$0.04 (vs NT$0.36 loss in 1Q 2020)

Full year 2020 earnings released: NT$1.24 loss per share (vs NT$2.21 loss in FY 2019)

What Type Of Returns Would Easywell Biomedicals'(GTSM:1799) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

New 90-day low: NT$16.10

Third quarter 2020 earnings released: NT$0.38 loss per share

New 90-day low: NT$14.95

New 90-day low: NT$16.50

New 90-day low - NT$18.10

First half earnings released

AMMINISTRATORE DELEGATO

Mandato